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Abstract
Haem oxygenase (heme,hydrogen-donor:oxygen oxidoreductase (α-methene-oxidizing, hydroxylating)), E.C.
1.14.99.3, converts heme into biliverdin and carbon monoxide, utilizing NADPH as cofactor.
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